Short answer: in melasma, Hollywood Spectra is not used as a one-off treatment that burns the pigment away. It is used as low-fluence laser toning spread across a series of sessions. The aim is not to destroy pigment in a single pass but to reduce the melanin load gradually. The reason is straightforward: melasma responds badly to aggressive energy, and high-fluence treatment can darken the patch rather than lighten it.
The device is based on Q-switched Nd:YAG technology and offers two wavelengths, 1064 nm and 532 nm. Melasma protocols use 1064 nm; this wavelength reaches deeper and makes it possible to work without overheating melanin in the epidermis. The 532 nm wavelength is preferred for more superficial, sharply defined sun spots and is not routinely used in melasma. The carbon peel performed with the same device targets pore appearance, oiliness and skin radiance, and should not be confused with melasma treatment. Our Hollywood Spectra technology page describes the equipment.
The schedule typically consists of a number of short sessions repeated every few weeks, with the result emerging gradually across the course. For the patient, the most important point is managing expectations: melasma is a chronic, relapsing condition. The laser is part of the treatment, not all of it. Without sun protection, appropriate topical therapy and control of triggers, whatever is gained from the laser usually does not last. Sun, heat, hormonal factors and certain medications can all set melasma off again.
For this reason the plan is almost always combined: regular use of a broad-spectrum, high-factor sunscreen, the topical treatment your doctor considers appropriate, and complementary approaches such as chemical peeling where indicated. It also matters that the pigmentation is properly assessed before treatment begins. Sun spots, post-inflammatory hyperpigmentation and melasma require different approaches, and the same protocol does not suit all three.
Limits and precautions: Hollywood Spectra does not permanently clear melasma; recurrence is possible and common. Treatment that is too intense or too frequent can produce unwanted outcomes such as mottled light patches from pigment loss, or darkening after treatment — which is why session frequency and energy settings stay under medical control. Treatment is postponed during pregnancy; melasma that appears in pregnancy is reassessed afterwards. Recently tanned skin, active infection or inflammation, recent isotretinoin use and photosensitising medications may all mean treatment should wait. Parameters require particular care in darker skin types.
Results vary considerably from person to person with skin type, the depth and duration of the melasma and hormonal status; no number of sessions or outcome can be guaranteed. Suitability and protocol can only be determined by a medical consultation.